Machine Learning Methods to Estimate Individualized Treatment Effects for Use in Health Technology Assessment

被引:1
|
作者
Zhang, Yingying [1 ]
Kreif, Noemi [1 ,3 ]
Gc., Vijay S. [2 ]
Manca, Andrea [1 ]
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, England
[2] Univ Huddersfield, Sch Human & Hlth Sci, Huddersfield, England
[3] Univ Washington, Dept Pharm, Seattle, WA USA
关键词
machine learning; causal inference; individualized treatment effect; health technology assessment; observational data; COST-EFFECTIVENESS ANALYSES; ECONOMIC-EVALUATION; CAUSAL INFERENCE; HETEROGENEITY;
D O I
10.1177/0272989X241263356
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Recent developments in causal inference and machine learning (ML) allow for the estimation of individualized treatment effects (ITEs), which reveal whether treatment effectiveness varies according to patients' observed covariates. ITEs can be used to stratify health policy decisions according to individual characteristics and potentially achieve greater population health. Little is known about the appropriateness of available ML methods for use in health technology assessment.Methods In this scoping review, we evaluate ML methods available for estimating ITEs, aiming to help practitioners assess their suitability in health technology assessment. We present a taxonomy of ML approaches, categorized by key challenges in health technology assessment using observational data, including handling time-varying confounding and time-to event data and quantifying uncertainty.Results We found a wide range of algorithms for simpler settings with baseline confounding and continuous or binary outcomes. Not many ML algorithms can handle time-varying or unobserved confounding, and at the time of writing, no ML algorithm was capable of estimating ITEs for time-to-event outcomes while accounting for time-varying confounding. Many of the ML algorithms that estimate ITEs in longitudinal settings do not formally quantify uncertainty around the point estimates.Limitations This scoping review may not cover all relevant ML methods and algorithms as they are continuously evolving.Conclusions Existing ML methods available for ITE estimation are limited in handling important challenges posed by observational data when used for cost-effectiveness analysis, such as time-to-event outcomes, time-varying and hidden confounding, or the need to estimate sampling uncertainty around the estimates.Implications ML methods are promising but need further development before they can be used to estimate ITEs for health technology assessments.
引用
收藏
页码:756 / 769
页数:14
相关论文
共 50 条
  • [11] MACHINE LEARNING TO ESTIMATE INDIVIDUAL TREATMENT EFFECTS OF AZITHROMYCIN MAINTENANCE THERAPY IN COPD
    Janssens, Wim
    Verstraete, Kenneth
    Gyselinck, Iwein
    Huts, Helene
    De Vos, Maarten
    Lindberg, Sarah M.
    Albert, Richard K.
    Connett, John E.
    Djamin, Remco
    van der Eerden, Menno M.
    CHEST, 2023, 164 (04) : 6525A - 6525A
  • [12] Leveraging machine learning methods to estimate heterogeneous effects: father absence in China as an example
    Liu, Ran
    CHINESE SOCIOLOGICAL REVIEW, 2022, 54 (03) : 223 - 251
  • [13] Global and Individual Treatment Effects Using Machine Learning Methods
    Smith, Bevan, I
    Chimedza, Charles
    Buhrmann, Jacoba H.
    INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE IN EDUCATION, 2020, 30 (03) : 431 - 458
  • [14] Global and Individual Treatment Effects Using Machine Learning Methods
    Bevan I. Smith
    Charles Chimedza
    Jacoba H. Bührmann
    International Journal of Artificial Intelligence in Education, 2020, 30 : 431 - 458
  • [15] Machine Learning-Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention
    Afshar, Majid
    Linck, Emma J. Graham
    Spicer, Alexandra B.
    Rotrosen, John
    Salisbury-Afshar, Elizabeth M.
    Sinha, Pratik
    Semler, Matthew W.
    Churpek, Matthew M.
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (05) : 511 - 519
  • [16] Do machine learning methods lead to similar individualized treatment rules? A comparison study on real data
    Bouvier, Florie
    Peyrot, Etienne
    Balendran, Alan
    Segalas, Corentin
    Roberts, Ian
    Petit, Francois
    Porcher, Raphael
    STATISTICS IN MEDICINE, 2024, 43 (11) : 2043 - 2061
  • [17] Assessment of Published Papers on the Use of Machine Learning in Diagnosis and Treatment of Mastitis
    Bourganou, Maria V.
    Kiouvrekis, Yiannis
    Chatzopoulos, Dimitrios C.
    Zikas, Sotiris
    Katsafadou, Angeliki I.
    Liagka, Dimitra V.
    Vasileiou, Natalia G. C.
    Fthenakis, George C.
    Lianou, Daphne T.
    INFORMATION, 2024, 15 (08)
  • [18] From Real-World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods to Address Underlying Challenges
    Bica, Ioana
    Alaa, Ahmed M.
    Lambert, Craig
    van der Schaar, Mihaela
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (01) : 87 - 100
  • [19] Use of web technology and active learning strategies in a quality assessment methods course
    Poirier, TI
    O'Neil, CK
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2000, 64 (03) : 289 - 296
  • [20] Learning Overlapping Representations for the Estimation of Individualized Treatment Effects
    Zhang, Yao
    Bellot, Alexis
    van der Schaar, Mihaela
    INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND STATISTICS, VOL 108, 2020, 108 : 1005 - 1013